Brief: Arrowhead Pharmaceuticals Q2 EPS USD -0.93
07/05/2026 21:01
May 07 (Reuters) - Arrowhead Pharmaceuticals Q2 revenue USD 73.737 million vs. IBES estimate USD 80 million. Q2 operating income USD -141.26 million Q2 operating expenses USD 214.997 million Q2 net income USD -4.84 million
Recent news on Arrowhead Pharmaceuticals
See all newsBrief: Uk's MHRA Authorises Redemplo For Adults With Familial Chylomicronaemia Syndrome
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Brief: Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers